Trials / Withdrawn

WithdrawnNCT05256498

AURA 1: Augmenting Urinary Reflex Activity: Study 1

Electrophysiological Studies of the Human Pudendal Nerve Using Short-duration Extracorporeal Stimulation

Status: Withdrawn
Phase: N/A
Study type: Interventional
Enrollment: 0 (actual)

Sponsor: Amber Therapeutics Ltd · Industry
Sex: Female
Age: 18 Years – 75 Years
Healthy volunteers: Not accepted

Summary

AURA 1 (Augmenting Urinary Reflex Activity: study 1) is a study that evaluates the electrophysiological responses of pudendal nerve stimulation using short-duration extracorporeal stimulation

Conditions

Overactive Bladder
Urge Incontinence

Interventions

Type	Name	Description
DEVICE	Picostim Amber	Picostim Amber temporary (24h) lead placement and extracorporeal stimulation

Timeline

Start date: 2022-04-01
Primary completion: 2022-12-01
Completion: 2022-12-01
First posted: 2022-02-25
Last updated: 2023-02-02

Source: ClinicalTrials.gov record NCT05256498. Inclusion in this directory is not an endorsement.